|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/7088 | (2006.01) | ||
| C12N 9/04 | (2006.01) |
| (11) | Number of the document | 3581654 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19182616.3 |
| Date of filing the European patent application | 2014-12-26 | |
| (97) | Date of publication of the European application | 2019-12-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation | 2021-06-25 |
| (30) | Number | Date | Country code |
| 201361921181 P | 2013-12-27 | US | |
| 201461937838 P | 2014-02-10 | US |
| (72) |
BROWN, Bob, D., US
DUDEK, Henryk, T., US
|
| (73) |
Dicerna Pharmaceuticals, Inc.,
33 Hayden Avenue, Lexington, Massachusetts 02421,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Būdai ir kompozicijos, skirti glikolato oksidazės (HAO1) specifinei inhibicijai dvigrande RNR |
| METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GLYCOLATE OXIDASE (HAO1) BY DOUBLE-STRANDED RNA |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 11 | 289.00 EUR |
| 2025-12-26 |